Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About MedInvestNews
BioSig Technologies
Biotech Insights
Biotech News
Cannabis & CBD
CEO Interviews
Citius Pharmaceuticals
Content & Advertising
Drug Manufacturers
Funds & Investment Banks
Hemispherx BioPharma
Immunotherapy & Biotech
iPhone
Latest Interviews
Medical Cannabis
Medical Equipment & Supplies
Mining Stocks
Mobile Apps & SaaS
Nano Dimension
Origin Clear
Pacific Green Technologies
Past Roadshows
Payements & Blockchain
Saas & Mobile
Services
Stock Geeks
Surge Holdings
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Stemline Therapeutics Acquired by Menarini Group for $677 Million
BiotechStocktrader
-
May 13, 2020
0
Akebia Stock Soars on Positive Kidney Drug Data, Q1 Results
BiotechStocktrader
-
May 13, 2020
0
MacroGenics Reports Strong Q1 Results, Pipeline Progress
BiotechStocktrader
-
May 13, 2020
0
Biotech Insights
Home
Biotech Insights
Page 2
Biotech Insights
Verastem Announces Ovarian Cancer Treatment Data
BiotechStocktrader
-
May 8, 2020
0
Biotech Insights
ImmunoGen Reports Narrower Q1 Loss, Recent Progress
BiotechStocktrader
-
May 8, 2020
0
Biotech Insights
Athersys Provides Update on COVID-19, Trauma Studies
BiotechStocktrader
-
May 8, 2020
0
1
2
Page 2 of 2
- Advertisement -
LATEST NEWS
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002
BiotechStocktrader
-
May 8, 2020
ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference
BiotechStocktrader
-
May 8, 2020
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3...
BiotechStocktrader
-
May 8, 2020
Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program
BiotechStocktrader
-
May 1, 2019
LATEST INTERVIEWS
Precision Therapeutics (AIPT) Bringing AI to Precision Medicine
BiotechStocktrader
-
December 4, 2018
0
Latest Interviews
In this episode of CEOLIVE.TV we are joined by Richard Gabriel, COO of TumorGenesis, a wholly owned subsidiary of Precision Therapeutics, ticker AIPT. About Precision...
381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832
Edit with Live CSS
